Literature DB >> 27170605

Bilateral dacryoadenitis as initial presentation of a locally aggressive and unresponsive limited form of orbital granulomatosis with polyangiitis.

Rute Lopes Caçola1, Sandra Alves Morais1, Rui Carvalho2, Rui Môço1.   

Abstract

Limited orbital granulomatosis with polyangiitis (GPA) is uncommon and its diagnosis may be delayed, especially when isolated lacrimal involvement is the initial presentation, because clinical manifestations are non-specific and systemic diagnostic criteria are not applicable. Making an early diagnosis despite the absence of systemic progression is extremely important because in some cases the disease is locally destructive, with irreversible visual and functional loss, and it can be refractory to corticosteroids and conventional immunosuppressive drugs to induce remission. The authors report an unusual limited form of orbital GPA in a 35-year-old woman presenting with bilateral dacryoadenitis, evolving later to locally aggressive bilateral orbital pseudotumour leading to proptosis, extraocular myositis, diplopia and medial deviation of the nasal septum. She had never had systemic manifestations but her disease was persistently active and unresponsive to corticosteroids and immunosuppressors. The aim of this paper is to provide further evidence of aggressive and refractory limited forms of GPA. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 27170605      PMCID: PMC4885259          DOI: 10.1136/bcr-2015-214099

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  31 in total

1.  Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.

Authors:  Rachel B Jones; Jan Willem Cohen Tervaert; Thomas Hauser; Raashid Luqmani; Matthew D Morgan; Chen Au Peh; Caroline O Savage; Mårten Segelmark; Vladimir Tesar; Pieter van Paassen; Dorothy Walsh; Michael Walsh; Kerstin Westman; David R W Jayne
Journal:  N Engl J Med       Date:  2010-07-15       Impact factor: 91.245

2.  Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): ten-year experience at a single center.

Authors:  Rodrigo Cartin-Ceba; Jason M Golbin; Karina A Keogh; Tobias Peikert; Marta Sánchez-Menéndez; Steven R Ytterberg; Fernando C Fervenza; Ulrich Specks
Journal:  Arthritis Rheum       Date:  2012-11

3.  Rituximab for the treatment of relapses in antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  E M Miloslavsky; U Specks; P A Merkel; P Seo; R Spiera; C A Langford; G S Hoffman; C G M Kallenberg; E W St Clair; N K Tchao; L Viviano; L Ding; D Iklé; M Villarreal; B Jepson; P Brunetta; N B Allen; F C Fervenza; D Geetha; K Keogh; E Y Kissin; P A Monach; T Peikert; C Stegeman; S R Ytterberg; J H Stone
Journal:  Arthritis Rheumatol       Date:  2014-11       Impact factor: 10.995

4.  Molecular diagnosis of orbital inflammatory disease.

Authors:  James T Rosenbaum; Dongseok Choi; David J Wilson; Hans E Grossniklaus; Cailin H Sibley; Christina A Harrington; Stephen R Planck
Journal:  Exp Mol Pathol       Date:  2015-01-14       Impact factor: 3.362

5.  Australasian orbital and adnexal Wegener's granulomatosis.

Authors:  T L Woo; I C Francis; G A Wilcsek; M T Coroneo; A A McNab; T J Sullivan
Journal:  Ophthalmology       Date:  2001-09       Impact factor: 12.079

6.  Unilateral dacryoadenitis as the sole presenting sign of Wegener's granulomatosis.

Authors:  Hayyam Kiratli; Mehmet Ali Sekeroğlu; Figen Soylemezoğlu
Journal:  Orbit       Date:  2008

7.  Wegener's granulomatosis presenting as dacryoadenitis.

Authors:  J A Leavitt; S I Butrus
Journal:  Cornea       Date:  1991-11       Impact factor: 2.651

Review 8.  Orbital Wegener's granulomatosis: a case report and review of the literature.

Authors:  John A Vischio; Christine T McCrary
Journal:  Clin Rheumatol       Date:  2008-07-05       Impact factor: 2.980

Review 9.  Orbital granulomatosis with polyangiitis (Wegener granulomatosis): clinical and pathologic findings.

Authors:  Karra Muller; Jonathan H Lin
Journal:  Arch Pathol Lab Med       Date:  2014-08       Impact factor: 5.534

Review 10.  State of the art in the treatment of systemic vasculitides.

Authors:  Raashid Ahmed Luqmani
Journal:  Front Immunol       Date:  2014-10-13       Impact factor: 7.561

View more
  1 in total

1.  Dacryoadenitis with Ptosis and Diplopia as the Initial Presentation of Granulomatosis with Polyangiitis.

Authors:  Makoto Hibino; Tetsuri Kondo
Journal:  Intern Med       Date:  2017-09-06       Impact factor: 1.271

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.